Covestor LTD Enanta Pharmaceuticals Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Covestor LTD holds 4 shares of ENTA stock, worth $36. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 4 -0.0%

Holding current value

$36

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$10.08 - $17.46 $10 - $17	-1 Reduced 20.0%	4 $0
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $11 - $22	1 Added 25.0%	5 $0
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $20 - $39	1 Added 33.33%	4 $0
Q4 2022 Feb 13, 2023	SELL	$40.77 - $53.73 $40 - $53	-1 Reduced 25.0%	3 $0
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $48 - $71	1 Added 33.33%	4 $0
Q2 2022 Aug 10, 2022	SELL	$38.13 - $76.93 $76 - $153	-2 Reduced 40.0%	3 $0
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $56 - $74	-1 Reduced 16.67%	5 $0
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $361 - $584	6 New	6 $0

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $188M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account